The first draft of DSM-V

BMJ (Online)

Volumn 340, Issue 7745, 2010, Pages 492-

  Frances, Allen ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DSM V; EDITORIAL; FALSE POSITIVE RESULT; HUMAN; INSURANCE; INTERNET; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; STIGMA; UNITED STATES;

EID: 77749306403     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1168     Document Type: Editorial

References (9)

1. Frances A. Opening Pandora's box: the 19 worst suggestions for DSM5. Psychiatr Times 2010. www.psychiatrictimes.com/home/content/article/10168/ 1522341
2. Kupfer D, Regier D, Kuhl E. On the road to DSM-V and ICD-11. Eur Arch Psychiatry Clin Neurosci 2008;258(suppl 5):2-6.[CrossRef][Web of Science][Medline]
3. Kendler K, Kupfer D, Narrow W, Phillips K, Fawcett J. Guidelines for making changes to DSM-V. American Psychiatric Association. www.psych.org/ MainMenu/Research/DSMIV/DSMV/DSMRevisionActivities/Guidelines-for-Making- Changes-to-DSM-1.aspx.
4. Spitzer RL. DSM-V: open and transparent? Psychiatr News 2008;43:26.[Free Full Text]
5. Frances A. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatr Times 2009. www.psychiatrictimes.com/display/article/ 10168/1425378?verify=0.
6. Frances A. Whither DSM-V? Br J Psychiatry 2009;195:391-2. [Abstract/Free Full Text]
7. Widiger T, Frances A, Pincus H, Davis W, First M. Toward an empirical classification for the DSM-IV. J Abnorm Psychol 1991;100:280-8.[CrossRef] [Web of Science][Medline]
8. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009;58:1-20.[Medline]
9. Correl CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009;302;1765-73.